Back to the Virtual Exhibit Hall

ADC Therapeutics SA operates as a clinical-stage oncology drug discovery and development company. The Company focuses on advancing highly potent and targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. ADC Therapeutics serves customers in the United States, Switzerland, and the United Kingdom.

DLBCL Treatment Zylonta

Advancing Patient Support Site



Dawn Fratto

Hematology Therapeutic Specialist - Pittsburgh

ADC Therapeutics



PDF icon CVA.pdf

PDF icon ZYNLONTA_Getting_Started_Brochure.pdf

PDF icon correct zynlonta-dosing-and-administration-guide-0421.pdf